Tianjin Chase Sun Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021
October 28, 2021 at 01:28 pm IST
Tianjin Chase Sun Pharmaceutical Co.,Ltd reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 5,486.44 million compared to CNY 4,708.51 million a year ago. Net income was CNY 637.08 million compared to CNY 599.13 million a year ago. Basic earnings per share from continuing operations was CNY 0.21 compared to CNY 0.2 a year ago. Diluted earnings per share from continuing operations was CNY 0.21 compared to CNY 0.2 a year ago.